2018GastroenterologyRequires access

Mo1845 - Higher Serum Concentrations of Vedolizumab are Associated with Superior Endoscopic Outcomes in Crohn's Disease: Data from the Love-CD Trial

Sophie E. Berends, Mark Löwenberg, Filip J. Baert, Ron A. A. Mathôt, Esmé Clasquin, C. Janneke van der Woude, Frank Hoentjen, Peter Bossuyt, Denis Franchimont, Theo Rispens, Annick de Vries, Séverine Vermeire, Geert D’Haens

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vedolizumab, Crohn's disease, Medicine, Internal medicine, Gastroenterology, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Mo1845 - Higher Serum Concentrations of Vedolizumab are Associated with Superior Endoscopic Outcomes in Crohn's Disease: Data from the Love-CD Trial — Research Paper | ScholarLens